Jeffrey A. Rona - 20 Feb 2025 Form 4 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
CBFO
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
OVID
Transactions as of
20 Feb 2025
Net transactions value
$0
Form type
4
Filing time
24 Feb 2025, 19:55:07 UTC
Previous filing
19 Dec 2024
Next filing
28 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OVID Common Stock Award $0 +43,750 +156% $0.000000 71,875 20 Feb 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OVID Employee Stock Option (Right to Buy) Award $0 +262,500 $0.000000 262,500 20 Feb 2025 Common Stock 262,500 $0.5700 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award. The RSUs will vest in three equal annual installments commencing on February 22, 2026, subject to the Reporting Person's continuous service through each such vesting date.
F2 Each RSU represents a contingent right to receive one share of Common Stock.
F3 The shares subject to the stock option will vest in 48 equal monthly installments commencing on March 20, 2025, subject to the Reporting Person's continued services through each such date.